cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1562-9. doi: 10.1016/j.ijrobp.2009.08.007.

Abstract

Purpose: To elucidate changes in gene expression after treatment with regional thermochemoradiotherapy in locally advanced squamous cell cervical cancer.

Methods and materials: Tru-Cut biopsy specimens were serially collected from 16 patients. Microarray gene expression levels before and 24 h after the first and second trimodality treatment sessions were compared. Pathway and network analyses were conducted by use of Ingenuity Pathways Analysis (IPA; Ingenuity Systems, Redwood City, CA). Single gene expressions were analyzed by quantitative real-time reverse transcription-polymerase chain reaction.

Results: We detected 53 annotated genes that were differentially expressed after trimodality treatment. Central in the three top networks detected by IPA were interferon alfa, interferon beta, and interferon gamma receptor; nuclear factor kappaB; and tumor necrosis factor, respectively. These genes encode proteins that are important in regulation cell signaling, proliferation, gene expression, and immune stimulation. Biological processes over-represented among the 53 genes were fibrosis, tumorigenesis, and immune response.

Conclusions: Microarrays showed minor changes in gene expression after thermochemoradiotherapy in locally advanced cervical cancer. We detected 53 differentially expressed genes, mainly involved in fibrosis, tumorigenesis, and immune response. A limitation with the use of serial biopsy specimens was low quality of ribonucleic acid from tumors that respond to highly effective therapy. Another "key limitation" is timing of the post-treatment biopsy, because 24 h may be too late to adequately assess the impact of hyperthermia on gene expression.

Publication types

  • Clinical Trial, Phase II
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Biopsy
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / therapy
  • Carcinoma, Squamous Cell / virology
  • Cervix Uteri / pathology
  • Cisplatin / administration & dosage
  • Combined Modality Therapy / methods
  • Female
  • Humans
  • Hyperthermia, Induced / methods
  • Interferon gamma Receptor
  • Interferon-alpha / genetics
  • Interferon-beta / genetics
  • Middle Aged
  • NF-kappa B / genetics
  • Neoplasm Proteins / genetics*
  • Norway
  • Oligonucleotide Array Sequence Analysis / methods*
  • Radiotherapy Dosage
  • Receptors, Interferon / genetics
  • Time Factors
  • Tumor Necrosis Factor-alpha / genetics
  • Uterine Cervical Neoplasms / genetics*
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / therapy
  • Uterine Cervical Neoplasms / virology

Substances

  • Antineoplastic Agents
  • Interferon-alpha
  • NF-kappa B
  • Neoplasm Proteins
  • Receptors, Interferon
  • Tumor Necrosis Factor-alpha
  • Interferon-beta
  • Cisplatin